Männer Gesundheitscheck

Male hormone and prostate health panel covering testosterone, DHEA-S, FSH, LH, prolactin, PSA, SHBG, and TSH. At €175.03 all-in, a targeted screen for men experiencing fatigue, libido changes, or wanting proactive prostate and hormonal health monitoring.

The Männer Gesundheitscheck is a focused endocrine panel addressing the hormonal and prostate-related concerns most relevant to adult men. The selection of markers provides a comprehensive picture of the hypothalamic-pituitary-gonadal axis alongside the single most clinically validated prostate cancer screening marker. Testosterone is the primary androgen, and its measurement is the starting point for evaluating suspected hypogonadism. Age-related decline begins around 30, with levels dropping approximately 1-2% per year. Symptoms of low testosterone — fatigue, decreased libido, reduced muscle mass, increased body fat, mood changes, and cognitive dulling — overlap heavily with general ageing, making laboratory confirmation essential before considering any intervention. SHBG (sex hormone-binding globulin) is critical context for interpreting testosterone. Most circulating testosterone is bound to SHBG and is biologically inactive. A man with normal total testosterone but elevated SHBG may have functionally low free testosterone, experiencing symptoms despite apparently normal levels. The free androgen index (total testosterone / SHBG) provides a calculated estimate of bioavailable testosterone. FSH and LH are the pituitary gonadotrophins that drive testicular function. Elevated FSH/LH with low testosterone indicates primary testicular failure (the testes themselves are underperforming). Low FSH/LH with low testosterone suggests secondary hypogonadism (the pituitary is not sending adequate signals), which may indicate a pituitary tumour, chronic illness, or medication effect — a distinction with very different treatment implications. DHEA-S is an adrenal androgen precursor that declines progressively with age. It serves as a marker of adrenal function and overall anabolic reserve. Low DHEA-S alongside low testosterone may suggest broader adrenal insufficiency. Prolactin is included to rule out hyperprolactinaemia, which can suppress testosterone production and cause gynecomastia, sexual dysfunction, and infertility. The most common cause is a prolactin-secreting pituitary adenoma, which is treatable with medication. PSA (prostate-specific antigen) is the standard prostate cancer screening marker. While its use as a population screening tool remains debated due to false positives and overdiagnosis concerns, PSA is clinically useful for men with symptoms, family history, or as a baseline measurement from age 45-50. Trends over time are more informative than single values. TSH is included because thyroid dysfunction can mimic or exacerbate many symptoms attributed to low testosterone, including fatigue, weight changes, and mood disturbance. Ruling out thyroid disease is a standard part of any fatigue or hormonal workup.